Inappropriate expression of full‐length DUX4 (DUX4‐fl – henceforth called DUX4) and activation of its target genes is likely the critical molecular event driving FSHD pathology (Lemmers et al, 2010). This evidence concerns the gene DUX4 and facioscapulohumeral muscular dystrophy.